BioSig Technologies, Inc. STEX Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $5M+3,719% | $3.53M+1,779% | $2.09M+734% | $636K+104% | $131K-63.1% | ||
| -$2.91M-251% | $196K-92.2% | $774.75K— | $1.35M— | $1.93M— | ||
| —— | —— | —— | —— | —— | ||
| -$506.66M-5,102% | -$462.78M-4,380% | -$39.87M-161% | -$26.2M-46.1% | -$9.74M+61.2% | ||
| -$9.71-1,546% | -$9.58-1,083% | -$1.38+1.4% | -$1.03+45.5% | -$0.59+81.4% | ||
| 283.6M+344% | 129.8M+145% | 95.9M+107% | 78.7M+109% | 63.9M+101% | ||
| 283.6M+344% | 129.8M+145% | 95.9M+107% | 78.7M+109% | 63.9M+101% | ||
| -$5.76M— | -$7.02M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $8.05M— | —— | —— | —— | ||
| $80.4M+902% | $57.1M+715% | $8.29M-2.0% | $8.96M+29.1% | $8.02M+10.7% | ||
| -$507.76M-5,113% | -$461.96M-4,372% | -$40.65M— | -$24.66M— | -$9.74M— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | -$102K+70.9% | -$145K+62.7% | -$267K+19.1% | -$308K+13.3% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $48.54M+517% | $54.88M+1,065% | $18.1M+143% | $4.7M-55.1% | $7.87M-35.1% | ||
| —— | —— | —— | —— | —— | ||
| -$19.5M-328% | -$10.44M-119% | -$7.89M-9.2% | -$4.36M+54.5% | -$4.56M+64.9% | ||
| —— | $96K-69.6% | $137K-61.1% | $243K-20.1% | $280K— | ||
| —— | —— | —— | —— | $3.99M-58.4% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$98.85M-705% | -$67.56M-433% | -$28.55M-62.3% | -$26.85M-44.1% | -$12.28M+49.3% | ||
| -$103.86M-737% | -$71.1M-453% | -$30.65M-71.7% | -$27.48M-45.0% | -$12.41M+49.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is BioSig Technologies, Inc.'s revenue?
- BioSig Technologies, Inc. (STEX) generated $40.0K in revenue over the trailing twelve months, up 122.2% year over year.
- Is BioSig Technologies, Inc. profitable?
- BioSig Technologies, Inc. is not currently profitable: it reported a net loss of $506.7M over the trailing twelve months, a -25825.0% net margin.
- What are BioSig Technologies, Inc.'s profit margins?
- Gross margin is 80.1% and operating margin is -32155.0%, with a -25825.0% net margin.
- What is BioSig Technologies, Inc.'s earnings per share?
- BioSig Technologies, Inc.'s diluted EPS over the trailing twelve months is $-9.71.
- Where does BioSig Technologies, Inc.'s income statement data come from?
- Every line is extracted from BioSig Technologies, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
